The newly formed Hongene Advisory Board includes some of the brightest minds in the business. The three new board members bring a wealth of knowledge and expertise in business strategy, nucleic acid chemistry, and organic synthesis, as well as diverse perspectives to ensure strong strategic decision-making. This latest announcement reflects Hongene’s commitment to focus on innovation to fulfil its ambitious commercial objectives in the exciting and high-potential field of RNA manufacturing.
The new appointments to the Hongene Advisory Board include: Dr. John Maraganore is a renowned biotech executive who is best known for his role as the founding CEO at Alnylam Pharmaceuticals, a leading global biopharmaceutical company that has brought five RNAi therapeutic medicines to market to date. He is a member of the Board of Directors of multiple private and publicly traded companies and non-profit organizations and serves as an advisor to several venture and public company investment firms. Maraganore received his B.A., M.S. and Ph.D. in biochemistry and molecular biology from the University of Chicago.
Dr. Phil Baran is Professor of Chemistry at the Scripps Research Institute. He is globally known for his pioneering work on developing new methods for synthesizing complex organic compounds that are widely used in pharmaceutical, agrochemical and materials science sectors. He has co-founded multiple companies, and has won numerous awards for his research, including the MacArthur Fellowship. Baran received his B.S. in chemistry from New York University and his Ph.D. from the Scripps Research Institute.
Dr. Masad Damha is Distinguished James McGill Professor of Chemistry at McGill University. He is a leading expert in nucleic acid chemistry and has made significant contributions to the development of new methods for synthesizing and modifying nucleic acids. He has received numerous awards for his research, including the R.U.Lemieux Award from the Canadian Chemical Institute. Damha received his B.Sc. and Ph.D. in organic chemistry from McGill University.
